Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
1.150
+0.070 (6.48%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Company Description

Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.

The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona.

Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.

Picard Medical, Inc.
Picard Medical logo
Country United States
Founded 1981
IPO Date Aug 29, 2025
Industry Medical Devices
Sector Healthcare
Employees 75
CEO Patrick Schnegelsberg

Contact Details

Address:
1992 East Silverlake Road
Tucson, Arizona 85713
United States
Phone 520-545-1234
Website picardmedical.com

Stock Details

Ticker Symbol PMI
Exchange NYSEAMERICAN
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.00
CIK Code 0002030617
CUSIP Number 71953R108
ISIN Number US71953R1086
SIC Code 3841

Key Executives

Name Position
Patrick N. J. Schnegelsberg Chief Executive Officer and Director
Bernard Skaggs Chief Financial Officer
Matthew Schuster Chief Operating Officer
Dr. Frank Tinker Ph.D. Chief Technology Officer of SynCardia Systems, LLC

Latest SEC Filings

Date Type Title
Mar 2, 2026 8-K Current Report
Feb 26, 2026 8-K Current Report
Feb 19, 2026 DEFR14A Filing
Feb 19, 2026 DEF 14A Other definitive proxy statements
Feb 11, 2026 SCHEDULE 13G Filing
Feb 10, 2026 PRE 14A Other preliminary proxy statements
Feb 10, 2026 424B3 Prospectus
Feb 6, 2026 EFFECT Notice of Effectiveness
Feb 4, 2026 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jan 27, 2026 S-8 Securities to be offered to employees in employee benefit plans